| Charles Kirk Jessup, MD | |
|
1240 Huffman Mill Rd, Burlington, NC 27215-8700 | |
| (336) 538-7000 | |
| Not Available |
| Full Name | Charles Kirk Jessup |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 1240 Huffman Mill Rd, Burlington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790216042 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2020-00640 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alamance Regional Medical Center | Burlington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wake Forest Emergency Providers | 7012819816 | 218 |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company that owns a broad intellectual property portfolio including a unique self-delivering RNAi platform, today announced that results from a blinded panel and an Investigator review show that incision sites treated with RXI-109 after scar revision surgery achieved better scores as compared to control incision sites in the same subjects, three months post scar revision surgery.
Findings from a new UT Southwestern Medical Center study suggest that fat from certain foods we eat makes its way to the brain. Once there, the fat molecules cause the brain to send messages to the body's cells, warning them to ignore the appetite-suppressing signals from leptin and insulin, hormones involved in weight regulation.
Dyadic International, Inc., a leading biotechnology company focused on the development and manufacture of bioproducts based on its cutting-edge C1 technology to address the needs of multi-billion dollar markets for biofuels, biotherapeutics and industrial enzymes, announced today that it has signed a non-binding term sheet with EnGen Bio, Inc. for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for applications in biopharmaceutical drug development.
In a new study that could have implications for future drug discovery efforts for a number of neurodegenerative diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that the interaction between a pair of brain proteins has a substantial and previously unrecognized effect on memory formation.
› Verified 5 days ago
| Entity Name | Wake Forest Emergency Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396216735 PECOS PAC ID: 7012819816 Enrollment ID: O20190312003619 |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company that owns a broad intellectual property portfolio including a unique self-delivering RNAi platform, today announced that results from a blinded panel and an Investigator review show that incision sites treated with RXI-109 after scar revision surgery achieved better scores as compared to control incision sites in the same subjects, three months post scar revision surgery.
Findings from a new UT Southwestern Medical Center study suggest that fat from certain foods we eat makes its way to the brain. Once there, the fat molecules cause the brain to send messages to the body's cells, warning them to ignore the appetite-suppressing signals from leptin and insulin, hormones involved in weight regulation.
Dyadic International, Inc., a leading biotechnology company focused on the development and manufacture of bioproducts based on its cutting-edge C1 technology to address the needs of multi-billion dollar markets for biofuels, biotherapeutics and industrial enzymes, announced today that it has signed a non-binding term sheet with EnGen Bio, Inc. for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for applications in biopharmaceutical drug development.
In a new study that could have implications for future drug discovery efforts for a number of neurodegenerative diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that the interaction between a pair of brain proteins has a substantial and previously unrecognized effect on memory formation.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Kirk Jessup, MD 1008 Franklin St, Durham, NC 27701-4013 Ph: (914) 216-2864 | Charles Kirk Jessup, MD 1240 Huffman Mill Rd, Burlington, NC 27215-8700 Ph: (336) 538-7000 |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company that owns a broad intellectual property portfolio including a unique self-delivering RNAi platform, today announced that results from a blinded panel and an Investigator review show that incision sites treated with RXI-109 after scar revision surgery achieved better scores as compared to control incision sites in the same subjects, three months post scar revision surgery.
Findings from a new UT Southwestern Medical Center study suggest that fat from certain foods we eat makes its way to the brain. Once there, the fat molecules cause the brain to send messages to the body's cells, warning them to ignore the appetite-suppressing signals from leptin and insulin, hormones involved in weight regulation.
Dyadic International, Inc., a leading biotechnology company focused on the development and manufacture of bioproducts based on its cutting-edge C1 technology to address the needs of multi-billion dollar markets for biofuels, biotherapeutics and industrial enzymes, announced today that it has signed a non-binding term sheet with EnGen Bio, Inc. for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for applications in biopharmaceutical drug development.
In a new study that could have implications for future drug discovery efforts for a number of neurodegenerative diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that the interaction between a pair of brain proteins has a substantial and previously unrecognized effect on memory formation.
› Verified 5 days ago
Mary Funke, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-7000 | |
Dr. Anne-caroline M Garnier Norman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-716-2255 | |
Dr. Randolph Nicholas Brown, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-716-2255 | |
Paul Malinda, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-7050 Fax: 336-538-7041 | |
Caitlin Jernigan Rodgers, PA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-7000 | |
Dr. Linda M Taylor, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-716-2255 | |
James Donald Strickland, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2708 Sturbridge Court, Burlington, NC 27215 Phone: 336-585-0938 |